phospho c jun Search Results


91
R&D Systems recombinant anti human phospho c jun
Recombinant Anti Human Phospho C Jun, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/pmc11334407-70-51-56?v=R%26D+Systems
Average 91 stars, based on 1 article reviews
recombinant anti human phospho c jun - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC phospho (thr202/tyr204; thr185/tyr187)/total erk1/2 assay whole-cell lysate kit
Phospho (Thr202/Tyr204; Thr185/Tyr187)/Total Erk1/2 Assay Whole Cell Lysate Kit, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/pmc11962398-111-5-13?v=Meso+Scale+Diagnostics+LLC
Average 90 stars, based on 1 article reviews
phospho (thr202/tyr204; thr185/tyr187)/total erk1/2 assay whole-cell lysate kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lallemand inc phospho-c-jun monoclonal antibody
Phospho C Jun Monoclonal Antibody, supplied by Lallemand inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/10__1523_slash_jneurosci__18___02___00751__1998-74-14-41?v=Lallemand+inc
Average 90 stars, based on 1 article reviews
phospho-c-jun monoclonal antibody - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Becton Dickinson anti-phospho-c-jun (s63) (dilution ratio 1:1000)
Anti Phospho C Jun (S63) (Dilution Ratio 1:1000), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/pmc07199950-37-19-31?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
anti-phospho-c-jun (s63) (dilution ratio 1:1000) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC phospho-c-jun whole cell lysate kit
Phospho C Jun Whole Cell Lysate Kit, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/pmc03174326-127-7-12?v=Meso+Scale+Diagnostics+LLC
Average 90 stars, based on 1 article reviews
phospho-c-jun whole cell lysate kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Promega phosphospecific phosphoerk (t183
Phosphospecific Phosphoerk (T183, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/10__1158_slash_1078___0432__ccr___07___4405-114-3-6?v=Promega
Average 90 stars, based on 1 article reviews
phosphospecific phosphoerk (t183 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lallemand inc anti-phospho-c-jun (ser63)
Anti Phospho C Jun (Ser63), supplied by Lallemand inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/pm19343038-178-62-67?v=Lallemand+inc
Average 90 stars, based on 1 article reviews
anti-phospho-c-jun (ser63) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Assay Designs Inc phospho-c-jun n-terminal protein kinase 1/2 (phospho-jnk1/2; thr183/tyr185
ROS-dependent hyperactivation of p38 MAPK is critical for FasL/CCN1-induced apoptosis. (A, top) Apoptosis of HSFs treated with vehicle (dimethyl sulfoxide), the p38 MAPK inhibitor SB203580 or SB202190 (10 μM each), or the JNK inhibitor SP600125 (12 μM) prior to stimulation with FasL with or without CCN1. *, P < 0.05; **, P < 0.01. (Bottom) Immunoblot analysis of caspase-9 processing in lysates of cells treated as indicated (B, BSA; C, CCN1; F, FasL; CF, CCN1 and FasL), with or without preincubation with 40 μM SB203580. (B) HSFs were treated with various proteins, and total cell lysates, collected after 4 h of incubation, were analyzed for <t>phospho-JNK1/2</t> (Pi-JNK; <t>Thr183/Tyr185)</t> and total JNK1/2 by immunoblotting. (C) HSFs were pretreated with various concentrations of SP600125 for 1 h and left uninduced or induced with CCN1 and FasL (C+F) for 4 h. Whole-cell lysates were immunoblotted against phospho-c-Jun (Ser63) and β-actin. (D, top) Lysates from cells transfected with control or p38α siRNA were immunoblotted with antibodies against p38 MAPK and β-actin. (Bottom) Transfected cells were stimulated with CCN1 and/or FasL; apoptosis was scored 4 h thereafter. (E) HSFs were treated as indicated in the presence or absence of NAC. After 4 h, total lysates were collected and analyzed for phospho-p38 MAPK (Thr180/Tyr182) and total p38 by immunoblotting. (F) Cells transfected with control or SMPD2 siRNA or treated with the nSMase inhibitor GW4869 (20 μM) were stimulated with CCN1 and/or FasL as described above. Cell lysates were immunoblotted for phosphorylated and total p38.
Phospho C Jun N Terminal Protein Kinase 1/2 (Phospho Jnk1/2; Thr183/Tyr185, supplied by Assay Designs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/pmc02698731-137-4-13?v=Assay+Designs+Inc
Average 90 stars, based on 1 article reviews
phospho-c-jun n-terminal protein kinase 1/2 (phospho-jnk1/2; thr183/tyr185 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Active Motif transam tm ap-1/ phosphoc-jun enzyme-linked immunosorbant assay kits
ROS-dependent hyperactivation of p38 MAPK is critical for FasL/CCN1-induced apoptosis. (A, top) Apoptosis of HSFs treated with vehicle (dimethyl sulfoxide), the p38 MAPK inhibitor SB203580 or SB202190 (10 μM each), or the JNK inhibitor SP600125 (12 μM) prior to stimulation with FasL with or without CCN1. *, P < 0.05; **, P < 0.01. (Bottom) Immunoblot analysis of caspase-9 processing in lysates of cells treated as indicated (B, BSA; C, CCN1; F, FasL; CF, CCN1 and FasL), with or without preincubation with 40 μM SB203580. (B) HSFs were treated with various proteins, and total cell lysates, collected after 4 h of incubation, were analyzed for <t>phospho-JNK1/2</t> (Pi-JNK; <t>Thr183/Tyr185)</t> and total JNK1/2 by immunoblotting. (C) HSFs were pretreated with various concentrations of SP600125 for 1 h and left uninduced or induced with CCN1 and FasL (C+F) for 4 h. Whole-cell lysates were immunoblotted against phospho-c-Jun (Ser63) and β-actin. (D, top) Lysates from cells transfected with control or p38α siRNA were immunoblotted with antibodies against p38 MAPK and β-actin. (Bottom) Transfected cells were stimulated with CCN1 and/or FasL; apoptosis was scored 4 h thereafter. (E) HSFs were treated as indicated in the presence or absence of NAC. After 4 h, total lysates were collected and analyzed for phospho-p38 MAPK (Thr180/Tyr182) and total p38 by immunoblotting. (F) Cells transfected with control or SMPD2 siRNA or treated with the nSMase inhibitor GW4869 (20 μM) were stimulated with CCN1 and/or FasL as described above. Cell lysates were immunoblotted for phosphorylated and total p38.
Transam Tm Ap 1/ Phosphoc Jun Enzyme Linked Immunosorbant Assay Kits, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/pmc03259285-78-37-41?v=Active+Motif
Average 90 stars, based on 1 article reviews
transam tm ap-1/ phosphoc-jun enzyme-linked immunosorbant assay kits - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Becton Dickinson anti-phosphoc-jun
ROS-dependent hyperactivation of p38 MAPK is critical for FasL/CCN1-induced apoptosis. (A, top) Apoptosis of HSFs treated with vehicle (dimethyl sulfoxide), the p38 MAPK inhibitor SB203580 or SB202190 (10 μM each), or the JNK inhibitor SP600125 (12 μM) prior to stimulation with FasL with or without CCN1. *, P < 0.05; **, P < 0.01. (Bottom) Immunoblot analysis of caspase-9 processing in lysates of cells treated as indicated (B, BSA; C, CCN1; F, FasL; CF, CCN1 and FasL), with or without preincubation with 40 μM SB203580. (B) HSFs were treated with various proteins, and total cell lysates, collected after 4 h of incubation, were analyzed for <t>phospho-JNK1/2</t> (Pi-JNK; <t>Thr183/Tyr185)</t> and total JNK1/2 by immunoblotting. (C) HSFs were pretreated with various concentrations of SP600125 for 1 h and left uninduced or induced with CCN1 and FasL (C+F) for 4 h. Whole-cell lysates were immunoblotted against phospho-c-Jun (Ser63) and β-actin. (D, top) Lysates from cells transfected with control or p38α siRNA were immunoblotted with antibodies against p38 MAPK and β-actin. (Bottom) Transfected cells were stimulated with CCN1 and/or FasL; apoptosis was scored 4 h thereafter. (E) HSFs were treated as indicated in the presence or absence of NAC. After 4 h, total lysates were collected and analyzed for phospho-p38 MAPK (Thr180/Tyr182) and total p38 by immunoblotting. (F) Cells transfected with control or SMPD2 siRNA or treated with the nSMase inhibitor GW4869 (20 μM) were stimulated with CCN1 and/or FasL as described above. Cell lysates were immunoblotted for phosphorylated and total p38.
Anti Phosphoc Jun, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/pm16964287-201-46-48?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
anti-phosphoc-jun - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Cayman Chemical antibodies to phospho-c-jun
ROS-dependent hyperactivation of p38 MAPK is critical for FasL/CCN1-induced apoptosis. (A, top) Apoptosis of HSFs treated with vehicle (dimethyl sulfoxide), the p38 MAPK inhibitor SB203580 or SB202190 (10 μM each), or the JNK inhibitor SP600125 (12 μM) prior to stimulation with FasL with or without CCN1. *, P < 0.05; **, P < 0.01. (Bottom) Immunoblot analysis of caspase-9 processing in lysates of cells treated as indicated (B, BSA; C, CCN1; F, FasL; CF, CCN1 and FasL), with or without preincubation with 40 μM SB203580. (B) HSFs were treated with various proteins, and total cell lysates, collected after 4 h of incubation, were analyzed for <t>phospho-JNK1/2</t> (Pi-JNK; <t>Thr183/Tyr185)</t> and total JNK1/2 by immunoblotting. (C) HSFs were pretreated with various concentrations of SP600125 for 1 h and left uninduced or induced with CCN1 and FasL (C+F) for 4 h. Whole-cell lysates were immunoblotted against phospho-c-Jun (Ser63) and β-actin. (D, top) Lysates from cells transfected with control or p38α siRNA were immunoblotted with antibodies against p38 MAPK and β-actin. (Bottom) Transfected cells were stimulated with CCN1 and/or FasL; apoptosis was scored 4 h thereafter. (E) HSFs were treated as indicated in the presence or absence of NAC. After 4 h, total lysates were collected and analyzed for phospho-p38 MAPK (Thr180/Tyr182) and total p38 by immunoblotting. (F) Cells transfected with control or SMPD2 siRNA or treated with the nSMase inhibitor GW4869 (20 μM) were stimulated with CCN1 and/or FasL as described above. Cell lysates were immunoblotted for phosphorylated and total p38.
Antibodies To Phospho C Jun, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/10__1074_slash_jbc__m110__180893-77-6-29?v=Cayman+Chemical
Average 90 stars, based on 1 article reviews
antibodies to phospho-c-jun - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
ZenBio phospho-c-jun (ser63) (#382955)
MiR-21 increased the phosphorylation of c-Jun <t>(Ser63)</t> and ABCG2 via targeting PDCD4. (A) RT-PCR of miR-21 in RKO and HCT116 cells upon 10 µM of 5-FU treatment for 48 hours. (B) RT-PCR of the baseline expression of miR-21 in HCT116 and HCT116/FUR cells. (C) RT-PCR of the baseline expression of pdcd4 in RKO and RKO-KO (miR-21 knockout) cells. (D) Western blotting of the indicated proteins in RKO-KO and RKO cells. Relative expression of proteins was quantified using Image J, and normalized to GAPDH. (E) Western blotting of the indicated proteins in RKO cells, and RKO-KO cells transfected with mimic-miR-21 normal control (NC) or mimic-miR-21. Relative expression of proteins was quantified using Image J, normalized to GAPDH, and is shown as a ratio relative to that of RKO cells. (F) RT-PCR of pdcd4 in RKO and HCT116 cells transfected with miR-21 inhibitor NC or miR-21 inhibitor. (G) Western blotting of the indicated proteins in RKO or HCT116 cells transfected with miR-21 inhibitor NC or miR-21 inhibitor. Relative expression of proteins was quantified using Image J, normalized to GAPDH, and is shown as a ratio relative to that of miR-21 inhibitor NC. Results are expressed as mean ± SD of three independent experiments. *, P≤0.05; ***, P≤0.001.
Phospho C Jun (Ser63) (#382955), supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+c+jun/pmc07867943-157-5-17?v=ZenBio
Average 90 stars, based on 1 article reviews
phospho-c-jun (ser63) (#382955) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


ROS-dependent hyperactivation of p38 MAPK is critical for FasL/CCN1-induced apoptosis. (A, top) Apoptosis of HSFs treated with vehicle (dimethyl sulfoxide), the p38 MAPK inhibitor SB203580 or SB202190 (10 μM each), or the JNK inhibitor SP600125 (12 μM) prior to stimulation with FasL with or without CCN1. *, P < 0.05; **, P < 0.01. (Bottom) Immunoblot analysis of caspase-9 processing in lysates of cells treated as indicated (B, BSA; C, CCN1; F, FasL; CF, CCN1 and FasL), with or without preincubation with 40 μM SB203580. (B) HSFs were treated with various proteins, and total cell lysates, collected after 4 h of incubation, were analyzed for phospho-JNK1/2 (Pi-JNK; Thr183/Tyr185) and total JNK1/2 by immunoblotting. (C) HSFs were pretreated with various concentrations of SP600125 for 1 h and left uninduced or induced with CCN1 and FasL (C+F) for 4 h. Whole-cell lysates were immunoblotted against phospho-c-Jun (Ser63) and β-actin. (D, top) Lysates from cells transfected with control or p38α siRNA were immunoblotted with antibodies against p38 MAPK and β-actin. (Bottom) Transfected cells were stimulated with CCN1 and/or FasL; apoptosis was scored 4 h thereafter. (E) HSFs were treated as indicated in the presence or absence of NAC. After 4 h, total lysates were collected and analyzed for phospho-p38 MAPK (Thr180/Tyr182) and total p38 by immunoblotting. (F) Cells transfected with control or SMPD2 siRNA or treated with the nSMase inhibitor GW4869 (20 μM) were stimulated with CCN1 and/or FasL as described above. Cell lysates were immunoblotted for phosphorylated and total p38.

Journal:

Article Title: Fas-Mediated Apoptosis Is Regulated by the Extracellular Matrix Protein CCN1 (CYR61) In Vitro and In Vivo

doi: 10.1128/MCB.00064-09

Figure Lengend Snippet: ROS-dependent hyperactivation of p38 MAPK is critical for FasL/CCN1-induced apoptosis. (A, top) Apoptosis of HSFs treated with vehicle (dimethyl sulfoxide), the p38 MAPK inhibitor SB203580 or SB202190 (10 μM each), or the JNK inhibitor SP600125 (12 μM) prior to stimulation with FasL with or without CCN1. *, P < 0.05; **, P < 0.01. (Bottom) Immunoblot analysis of caspase-9 processing in lysates of cells treated as indicated (B, BSA; C, CCN1; F, FasL; CF, CCN1 and FasL), with or without preincubation with 40 μM SB203580. (B) HSFs were treated with various proteins, and total cell lysates, collected after 4 h of incubation, were analyzed for phospho-JNK1/2 (Pi-JNK; Thr183/Tyr185) and total JNK1/2 by immunoblotting. (C) HSFs were pretreated with various concentrations of SP600125 for 1 h and left uninduced or induced with CCN1 and FasL (C+F) for 4 h. Whole-cell lysates were immunoblotted against phospho-c-Jun (Ser63) and β-actin. (D, top) Lysates from cells transfected with control or p38α siRNA were immunoblotted with antibodies against p38 MAPK and β-actin. (Bottom) Transfected cells were stimulated with CCN1 and/or FasL; apoptosis was scored 4 h thereafter. (E) HSFs were treated as indicated in the presence or absence of NAC. After 4 h, total lysates were collected and analyzed for phospho-p38 MAPK (Thr180/Tyr182) and total p38 by immunoblotting. (F) Cells transfected with control or SMPD2 siRNA or treated with the nSMase inhibitor GW4869 (20 μM) were stimulated with CCN1 and/or FasL as described above. Cell lysates were immunoblotted for phosphorylated and total p38.

Article Snippet: Antibodies for caspase-8 and phospho-c-Jun N-terminal protein kinase 1/2 (phospho-JNK1/2; Thr183/Tyr185) were from Assay Designs, those for caspase-9, -3, phospho-p38 MAPK (Thr180/182), phospho-c-Jun (Ser63), and JNK1/2 were from Cell Signaling Technology, and those for p38 MAPK, Fas (C-20), and poly(ADP ribose) polymerase (PARP; H-250) were from Santa Cruz.

Techniques: Western Blot, Incubation, Transfection

MiR-21 increased the phosphorylation of c-Jun (Ser63) and ABCG2 via targeting PDCD4. (A) RT-PCR of miR-21 in RKO and HCT116 cells upon 10 µM of 5-FU treatment for 48 hours. (B) RT-PCR of the baseline expression of miR-21 in HCT116 and HCT116/FUR cells. (C) RT-PCR of the baseline expression of pdcd4 in RKO and RKO-KO (miR-21 knockout) cells. (D) Western blotting of the indicated proteins in RKO-KO and RKO cells. Relative expression of proteins was quantified using Image J, and normalized to GAPDH. (E) Western blotting of the indicated proteins in RKO cells, and RKO-KO cells transfected with mimic-miR-21 normal control (NC) or mimic-miR-21. Relative expression of proteins was quantified using Image J, normalized to GAPDH, and is shown as a ratio relative to that of RKO cells. (F) RT-PCR of pdcd4 in RKO and HCT116 cells transfected with miR-21 inhibitor NC or miR-21 inhibitor. (G) Western blotting of the indicated proteins in RKO or HCT116 cells transfected with miR-21 inhibitor NC or miR-21 inhibitor. Relative expression of proteins was quantified using Image J, normalized to GAPDH, and is shown as a ratio relative to that of miR-21 inhibitor NC. Results are expressed as mean ± SD of three independent experiments. *, P≤0.05; ***, P≤0.001.

Journal: Annals of Translational Medicine

Article Title: Repressing PDCD4 activates JNK/ABCG2 pathway to induce chemoresistance to fluorouracil in colorectal cancer cells

doi: 10.21037/atm-20-4292

Figure Lengend Snippet: MiR-21 increased the phosphorylation of c-Jun (Ser63) and ABCG2 via targeting PDCD4. (A) RT-PCR of miR-21 in RKO and HCT116 cells upon 10 µM of 5-FU treatment for 48 hours. (B) RT-PCR of the baseline expression of miR-21 in HCT116 and HCT116/FUR cells. (C) RT-PCR of the baseline expression of pdcd4 in RKO and RKO-KO (miR-21 knockout) cells. (D) Western blotting of the indicated proteins in RKO-KO and RKO cells. Relative expression of proteins was quantified using Image J, and normalized to GAPDH. (E) Western blotting of the indicated proteins in RKO cells, and RKO-KO cells transfected with mimic-miR-21 normal control (NC) or mimic-miR-21. Relative expression of proteins was quantified using Image J, normalized to GAPDH, and is shown as a ratio relative to that of RKO cells. (F) RT-PCR of pdcd4 in RKO and HCT116 cells transfected with miR-21 inhibitor NC or miR-21 inhibitor. (G) Western blotting of the indicated proteins in RKO or HCT116 cells transfected with miR-21 inhibitor NC or miR-21 inhibitor. Relative expression of proteins was quantified using Image J, normalized to GAPDH, and is shown as a ratio relative to that of miR-21 inhibitor NC. Results are expressed as mean ± SD of three independent experiments. *, P≤0.05; ***, P≤0.001.

Article Snippet: Antibodies specific for c-Jun (#380397), phospho-c-Jun (Ser63) (#382955), phospho-JNK (Thr183/Tyr185) (#619878), and b-actin (#200068-6D7) were obtained from Zen-Bio (Chengdu, China).

Techniques: Reverse Transcription Polymerase Chain Reaction, Expressing, Knock-Out, Western Blot, Transfection